extraction technology

The firm also released pro forma results for its Q1 — reflecting the dispositions of the specialty product lines — showing $2.1 million less in revenues than previously reported, while its cash position increased 45 percent.

Qiagen licensed HandyLab's extraction technology for use in the sample prep process for its HPV assays.

LCS has entered a market varyingly referred to as sequence capture, target enrichment, and sequence enrichment. While the firms playing in this application area cannot agree on a name for it, they all agree that the market has the potential to become, in LCS' words, "very large."

Febit plans to debut the method at Cambridge Healthtech Institute's Next-Generation Sequencing conference in San Diego next month.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.